B Acute Lymphoblastic Leukemia
Showing 1 - 23 of 23
B Acute Lymphoblastic Leukemia Trial (procedure, biological, drug, radiation)
Not yet recruiting
- B Acute Lymphoblastic Leukemia
- Biospecimen Collection
- +19 more
- (no location specified)
Nov 8, 2023
B Acute Lymphoblastic Leukemia, Ph-Negative ALL, High Risk Acute Lymphoblastic Leukemia Trial (Azacitidine Injection,
Not yet recruiting
- B Acute Lymphoblastic Leukemia
- +2 more
- Azacitidine Injection
- +2 more
- (no location specified)
Oct 15, 2023
B Acute Lymphoblastic Leukemia Trial in Duarte (drug, procedure, other)
Not yet recruiting
- B Acute Lymphoblastic Leukemia
- Autologous Anti-CD19 CAR-expressing T Lymphocytes
- +6 more
-
Duarte, CaliforniaCity of Hope Medical Center
Jan 30, 2023
B Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1, Recurrent B Acute
Recruiting
- B Acute Lymphoblastic Leukemia
- +2 more
- Dasatinib
- +4 more
-
Portland, OregonOHSU Knight Cancer Institute
Dec 16, 2022
B Acute Lymphoblastic Leukemia Trial in Suzhou (Blinatumomab)
Recruiting
- B Acute Lymphoblastic Leukemia
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow University, Jiangsu Ins
Nov 1, 2022
B Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1, Lymphoblastic Lymphoma Trial
Not yet recruiting
- B Acute Lymphoblastic Leukemia
- +5 more
- Biospecimen Collection
- +4 more
- (no location specified)
Oct 28, 2022
Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia, Mixed Phenotype Acute Leukemia Trial in Worldwide (procedure,
Recruiting
- Acute Lymphoblastic Leukemia
- +3 more
- Allogeneic Hematopoietic Stem Cell Transplantation
- +21 more
-
Birmingham, Alabama
- +219 more
Sep 15, 2022
B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma, Down Syndrome Trial in Worldwide (drug, biological, radiation)
Recruiting
- B Acute Lymphoblastic Leukemia
- +2 more
- Asparaginase Erwinia chrysanthemi
- +15 more
-
Birmingham, Alabama
- +219 more
Aug 24, 2022
B-Cell Lymphoma, B Acute Lymphoblastic Leukemia, Diffuse Large B Cell Lymphoma Trial in Pittsburgh (Chimeric Antigen Receptor
Recruiting
- B-Cell Lymphoma
- +8 more
- Chimeric Antigen Receptor (CAR) T-Cell Product (Autologous)
-
Pittsburgh, PennsylvaniaAHN Cancer Institute - West Penn Hospital
Aug 10, 2022
B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma Trial (Cyclophosphamide, Vincristine, Dexamethasone)
Not yet recruiting
- B Acute Lymphoblastic Leukemia
- B Lymphoblastic Lymphoma
- Cyclophosphamide
- +10 more
- (no location specified)
Aug 2, 2022
B Acute Lymphoblastic Leukemia, Ph-Like Acute Lymphoblastic Leukemia Trial in Duarte (Cyclophosphamide, Cytarabine, Daunorubicin
Recruiting
- B Acute Lymphoblastic Leukemia
- Ph-Like Acute Lymphoblastic Leukemia
- Cyclophosphamide
- +8 more
-
Duarte, CaliforniaCity of Hope Medical Center
Jul 26, 2022
B Acute Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia, in Relapse Trial (Decreasing starting times for beginning
Not yet recruiting
- B Acute Lymphoblastic Leukemia
- Acute Lymphoblastic Leukemia, in Relapse
- Decreasing starting times for beginning nivolumab (Time to Event Continual Reassessment Method (TITE-CRM) )
- Nivolumab starting at day -1
- (no location specified)
Apr 4, 2022
B Acute Lymphoblastic Leukemia Trial in London (PBLTT52CAR19)
Recruiting
- B Acute Lymphoblastic Leukemia
-
London, United KingdomGreat Ormond Street Hospital
Dec 15, 2021
Acute Leukemia of Ambiguous Lineage, B Acute Lymphoblastic Leukemia, Mixed Phenotype Acute Leukemia Trial in Worldwide
Active, not recruiting
- Acute Leukemia of Ambiguous Lineage
- +2 more
- Azacitidine
- +17 more
-
Birmingham, Alabama
- +173 more
Nov 16, 2021
Minimal Residual Disease(MRD)in Pediatric B-acute Lymphoblastic
Recruiting
- B Acute Lymphoblastic Leukemia
- Minimal residual disease (MRD) monitoring
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Jul 25, 2021
Acute Lymphoblastic Leukemia in Remission, B Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia, Philadelphia
Terminated
- Acute Lymphoblastic Leukemia in Remission
- +2 more
- Cyclophosphamide
- +12 more
-
Houston, TexasM D Anderson Cancer Center
Mar 18, 2021
B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma Trial in Houston (biological, drug, other)
Recruiting
- B Acute Lymphoblastic Leukemia
- B Lymphoblastic Lymphoma
- Blinatumomab
- +12 more
-
Houston, TexasM D Anderson Cancer Center
Feb 21, 2021
B Acute Lymphoblastic Leukemia, Recurrent Childhood Acute Lymphoblastic Leukemia, Refractory Childhood Acute Lymphoblastic
Completed
- B Acute Lymphoblastic Leukemia
- +3 more
- AUTO3 (CD19/22 CAR T cells
-
London, United Kingdom
- +2 more
Jan 11, 2021
B Acute Lymphoblastic Leukemia, Minimal Residual Disease, Recurrent Acute Lymphoblastic Leukemia Trial in Seattle (Laboratory
Terminated
- B Acute Lymphoblastic Leukemia
- +3 more
- Laboratory Biomarker Analysis
- Pembrolizumab
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Aug 11, 2020
B Acute Lymphoblastic Leukemia, Leukemia Relapse Trial in France (Collection of blood samples)
Unknown status
- B Acute Lymphoblastic Leukemia
- Leukemia Relapse
- Collection of blood samples
-
Amiens, France
- +17 more
Feb 4, 2020
B Acute Lymphoblastic Leukemia, Mantle Cell Lymphoma, Follicular Lymphoma Trial in Suzhou (CD19-CART)
Unknown status
- B Acute Lymphoblastic Leukemia
- +2 more
-
Suzhou, Jiangsu, ChinaHematology Department of the Second Affiliated Hospital of Suzho
Dec 1, 2019
B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma, Recurrent Adult Acute Lymphoblastic Leukemia Trial in Seattle (drug,
Withdrawn
- B Acute Lymphoblastic Leukemia
- +8 more
- Asparaginase
- +8 more
-
Seattle, WashingtonFred Hutchinson Cancer Research Center/University of Washington
Nov 9, 2018
B Acute Lymphoblastic Leukemia Trial in Kunming (prophylactic 4SCAR19 cells)
Unknown status
- B Acute Lymphoblastic Leukemia
- prophylactic 4SCAR19 cells
-
Kunming, Yunnan, ChinaFirst people's hospital of Yunnan province
Nov 17, 2016